SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Research and Technical Change in the Pharmaceutical Industry
0 references·14 citing·53 second hop
Research and Technical Change in the Pharmaceutical Industry (1965)Research and Technical Change in the Phar…Trade with innovation benefits: A re-appraisal using micro data from China (2023)Trade with innovation benefit…Is the Pharmaceutical Industry in a Productivity Crisis? (2006)Is the Pharmaceutical Industr…Research Productivity in the Japanese Pharmaceutical Industry: Economies of Scale, Economies of Scope and Spillovers (2004)Research Productivity in the …Impact of mergers & acquisitions on research productivity within the pharmaceutical industry (2004)Impact of mergers & acquisiti…International alliances as sources of capital (2000)International alliances as so…Managing an entrepreneurial organizational environment (1996)Managing an entrepreneurial o…R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry (1995)R&D Costs, Innovative Output …Industrial innovation and firm performance: A re-conceptualization and exploratory structural equation analysis (1993)Industrial innovation and fir…Research Expenditures and the Discovery of New Drugs (1987)Research Expenditures and the…Towards a theory of multinational enterprise (1986)Towards a theory of multinati…The Choice of Strategic Alternatives Under Increasing Regulation in High Technology Companies (1984)The Choice of Strategic Alter…Firm Size and Efficient Entrepreneurial Activity: A Reformulation of the Schumpeter Hypothesis (1980)Firm Size and Efficient Entre…Research and Development Costs and Returns: The U.S. Pharmaceutical Industry (1972)Research and Development Cost…Research and Development in Industrial Growth (1971)Research and Development in I…Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Firm Resources and Sustained Competitive Advantage (1991)R&D collaboration: role of Ba in knowledge-creating networks (2003)Firm resources and sustained competitive advantage (2004)The role of alumni attachment in the university technology transfer process (2013)Measuring Competence? Exploring Firm Effects in Pharmaceutical Research (1994)Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)Can the pharmaceutical industry reduce attrition rates? (2004)Retail price regulation and innovation: Reference pricing in the pharmaceutical industry (2009)Pharmaceutical Innovation (2010)How does basic research improve innovation performance in the world’s major pharmaceutical firms? (2021)Cost of innovation in the pharmaceutical industry (1991)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery (1996)The impact of ESG on firm value: The moderating role of cash holdings (2025)Competitive advantage, creating and sustaining superior performance (1985)Competitive Advantage: Creating and Sustaining Superior Performance (1985)Capitalism, Socialism and Democracy (1997)Product innovation and competitive advantage in an area of industrial decline: the Niagara region of Canada (2001)Stewardship Behavior and Creativity (2011)Is Aggregation Necessarily Bad? (1960)Economic Welfare and the Allocation of Resources for Invention (1962)Invention, Growth and Welfare. (1970)THE VERTICAL CHAIN OF RESEARCH AND DEVELOPMENT IN THE PHARMACEUTICAL INDUSTRY (1995)Are the Economics of Pharmaceutical Research and Development Changing? (2004)Competition and Entrepreneurship (1974)On nonparametric estimation of the Schumpeterian link between innovation and firm size: Evidence from Belgium, France, and Germany (1996)An econometric analysis of trends in research joint venture activity (2005)Capitalism, Socialism and Democracy (2010)Characteristics of Corporate R&D Investment in Emerging Markets: Evidence from Manufacturing Industry in China and South Korea (2018)Technical Change and the Aggregate Production Function (1957)Research Costs and Social Returns: Hybrid Corn and Related Innovations (1958)The Sources of Economic Growth in the United States and the Alternatives before Us. (1962)Industrial Research and Firm Size, Survival, and Growth in American Manufacturing, 1921–1946: An Assessment (1983)R & D Expenditures, Royalty Payments, and Sales Growth in Japanese Manufacturing Corporations (1983)R&D and Productivity Growth: A Review of the Literature (2007)The Nature of the Firm (1937)Markets and Hierarchies: Analysis and Antitrust Implications. (1976)Transaction-Cost Economics: The Governance of Contractual Relations (1979)Markets, false hierarchies and the evolution of the modern corporation (1992)Vers un nouveau mode d'externalisation : le crowdsourcing (2007)Influence of country and company characteristics on international business decisions: A review, conceptual model, and propositions (2018)Preemptive Patenting and the Persistence of Monopoly (1982)Limited-dependent and qualitative variables in econometrics (1983)Econometric Models for Count Data with an Application to the Patents-R & D Relationship (1984)Does R&D performance decline with firm size?—A re-examination in terms of elasticity (2005)The relation between firm size and R&D productivity in different technological regimes (2012)A Behavioral Theory of the Firm (1963)The Social Psychology of Organizations. (1979)Effects of regulatory uncertainty on corporate strategy—an analysis of firms’ responses to uncertainty about post-Kyoto policy (2009)Corporate response strategies to regulatory uncertainty: evidence from uncertainty about post-Kyoto regulation (2010)External Control of Organizations: Resource Dependence Perspective (2011)Regulating away competition: the effect of regulation on entrepreneurship and employment (2017)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 1984The Choice of Strategic Alternatives Under Increasing Regulation in High Technology Companies131 cited
  • 1987Research Expenditures and the Discovery of New Drugs108 cited
  • 1971Research and Development in Industrial Growth108 cited
  • 1972Research and Development Costs and Returns: The U.S. Pharmaceutical Industry96 cited
  • 1980Firm Size and Efficient Entrepreneurial Activity: A Reformulation of the Schumpeter Hypothesis91 cited
  • 2006Is the Pharmaceutical Industry in a Productivity Crisis?77 cited
  • 1993Industrial innovation and firm performance: A re-conceptualization and exploratory structural equation analysis70 cited
  • 1995R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry68 cited
  • 1986Towards a theory of multinational enterprise52 cited
  • 2000International alliances as sources of capital51 cited
  • 2004Impact of mergers & acquisitions on research productivity within the pharmaceutical industry27 cited
  • 1996Managing an entrepreneurial organizational environment22 cited
  • 2023Trade with innovation benefits: A re-appraisal using micro data from China19 cited
  • 2004Research Productivity in the Japanese Pharmaceutical Industry: Economies of Scale, Economies of Scope and Spillovers

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

13 cited